Iridex Reports Second Quarter 2026 Financial Results
IRIDEX Corporation (IRIX) Q2 2026 Earnings Call Transcript
Full Transcript: Iridex Q2 2026 Earnings Call
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est
Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering
Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe Handpieces
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
IRIDEX Corporation Q1 2026 Earnings Call Summary
Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens
Iridex Reports First Quarter 2026 Financial Results
IRIDEX Corporation (IRIX) Q1 2026 Earnings Call Transcript
Iridex Q1 2026 Earnings Call: Complete Transcript
Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.